Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Understanding the Tests Used for Brain Tumor Diagnosis
Neuroimaging is a very important part of the group of tools that doctors use to make an accurate diagnosis of a brain tumor. Neuroimaging tests allow physicians to see what is going on inside your brain. The tests use x-rays, strong magnets, or radioactive substances to create pictures of internal organs like the brain and spinal cord. The pictures are then analyzed by doctors specializing in the diagnosis and treatment of brain tumors (neurosurgeons, neurologists, and neuroradiologists) to arrive at the correct, detailed diagnosis.
Magnetic resonance imaging (MRI) and computed tomography (CT) scans are two of the neuroimaging techniques used most often to examine brain tumors. When a tumor is present, MRI or CT scans will almost always show it and can often tell the doctors exactly where the tumor is in the brain. They can also help indicate its severity. Imaging tests are sometimes repeated after treatment to measure improvement.
Stanford is the first medical center in Northern California to offer patients a powerful new diagnostic imaging system known as PET/CT. The most up-to-date imaging machines are needed for the most accurate diagnosis. These advanced machines are available to all of our patients undergoing a brain tumor assessment. This is a field that is evolving rapidly and Stanford’s advanced imaging machines are among the most sophisticated available anywhere.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.